Antigen Detection Assay for Diagnosis of Melioidosis

InBios International Inc0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•At least 5 years of age.
•Subject able to give written informed consent/assent as appropriate. Present with at least one of the following symptoms of melioidosis:
•Sepsis with unknown cause at the time of study enrollment, or Suspected cases of melioidosis by physician with a wide range of symptoms including: Type 2 diabetes with ulceration and abscesses and/or unhealed wounds; Swelling, open wounds/skin abrasions with pus; Multiple abscesses in kidneys, liver, spleen, prostate; Respiratory tract symptoms (sore throat, shortness of breath, pneumonia, cough); Fever with chills and other signs and symptoms consistent with melioidosis; Headache and other signs and symptoms consistent with melioidosis; Muscle soreness and other signs and symptoms consistent with melioidosis; Weight loss and other signs and symptoms consistent with melioidosis.

•Currently taking or have taken ceftazidime or meropenem targeting B. pseudomallei in the last 48 hours.
•Previous enrollment in this study.

发起方